Stockscreener 앱 받기
63.52
0.48%
-0.4695
전일 마감가:
$63.99
열려 있는:
$63.02
하루 거래량:
275.58K
Relative Volume:
0.11
시가총액:
$5.78B
수익:
$170.10M
순이익/손실:
$-239.59M
주가수익비율:
-22.69
EPS:
-2.8
순현금흐름:
$-191.20M
1주 성능:
-3.10%
1개월 성능:
-5.99%
6개월 성능:
+66.48%
1년 성능:
+25.45%
1일 변동 폭
$62.88
$64.74
1주일 범위
$60.53
$65.98
52주 변동 폭
$30.04
$78.48
크리스퍼 테라퓨틱스 Stock (CRSP) Company Profile
명칭
Crispr Therapeutics Ag
전화
(617) 315-4600
주소
BAARERSTRASSE 14, ZUG
CRSP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRSP
Crispr Therapeutics Ag
|
63.60 | 5.82B | 170.10M | -239.59M | -191.20M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.33 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.30 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.99 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
827.10 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.21 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
크리스퍼 테라퓨틱스 Stock (CRSP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 개시 | JP Morgan | Overweight |
| 2025-02-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-02-12 | 업그레이드 | TD Cowen | Sell → Hold |
| 2025-02-03 | 개시 | H.C. Wainwright | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-08-02 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-28 | 재개 | Guggenheim | Neutral |
| 2024-02-15 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-11 | 다운그레이드 | TD Cowen | Market Perform → Underperform |
| 2023-10-17 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-09-27 | 개시 | Mizuho | Buy |
| 2023-08-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-30 | 개시 | William Blair | Outperform |
| 2023-04-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-21 | 개시 | Bernstein | Mkt Perform |
| 2023-03-17 | 개시 | Bryan Garnier | Buy |
| 2023-03-07 | 개시 | Robert W. Baird | Neutral |
| 2022-10-11 | 개시 | Morgan Stanley | Underweight |
| 2022-08-09 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-06-23 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-04-28 | 개시 | Credit Suisse | Neutral |
| 2021-12-07 | 개시 | Cowen | Market Perform |
| 2021-10-19 | 개시 | SVB Leerink | Outperform |
| 2021-06-14 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-04-21 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-03-04 | 개시 | JMP Securities | Mkt Outperform |
| 2020-12-10 | 재확인 | Chardan Capital Markets | Buy |
| 2020-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-10 | 재확인 | Needham | Buy |
| 2020-12-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-10-23 | 개시 | RBC Capital Mkts | Sector Perform |
| 2020-10-05 | 개시 | BofA Securities | Buy |
| 2020-07-28 | 재확인 | Needham | Buy |
| 2020-07-14 | 개시 | SunTrust | Buy |
| 2020-06-15 | 재확인 | Canaccord Genuity | Buy |
| 2020-03-05 | 개시 | Stifel | Hold |
| 2020-02-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-11-19 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2019-11-12 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2019-08-01 | 개시 | Jefferies | Buy |
| 2019-07-26 | 개시 | Canaccord Genuity | Buy |
| 2019-06-10 | 개시 | ROTH Capital | Buy |
| 2019-04-12 | 개시 | Evercore ISI | Outperform |
| 2019-03-14 | 개시 | William Blair | Mkt Perform |
| 2019-01-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-01-22 | 다운그레이드 | Citigroup | Neutral → Sell |
모두보기
크리스퍼 테라퓨틱스 주식(CRSP)의 최신 뉴스
Should CRSP Stock Be in Your Portfolio Pre-Q3 Earnings? - Zacks Investment Research
What to do if you’re stuck in CRISPR Therapeutics AG2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - newser.com
Why CRISPR Therapeutics AG stock could rally in 2025Weekly Risk Summary & Daily Price Action Insights - newser.com
Can CRISPR Therapeutics AG (1CG) stock deliver double digit returnsJuly 2025 Closing Moves & Momentum Based Trading Signals - newser.com
Applying Wyckoff theory to CRISPR Therapeutics AG stock2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
Can CRISPR Therapeutics AG (1CG) stock double in coming yearsJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Key resistance and support levels for CRISPR Therapeutics AG2025 Market Sentiment & Community Consensus Trade Alerts - newser.com
How to build a dashboard for CRISPR Therapeutics AG stock2025 Retail Activity & Free Accurate Trade Setup Notifications - newser.com
Why CRISPR Therapeutics AG (1CG) stock is listed among top recommendationsQuarterly Trade Report & Smart Swing Trading Techniques - newser.com
Will CRISPR Therapeutics AG (1CG) stock gain from green policies2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
What valuation multiples suggest for CRISPR Therapeutics AG stock2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Is CRISPR Therapeutics AG stock cheap compared to fundamentalsMarket Trend Summary & Daily Oversold Stock Bounce Ideas - newser.com
Y Intercept Hong Kong Ltd Makes New $1.91 Million Investment in CRISPR Therapeutics AG $CRSP - MarketBeat
Wealthfront Advisers LLC Acquires Shares of 6,003 CRISPR Therapeutics AG $CRSP - MarketBeat
Has CRISPR Therapeutics AG found a price floorJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com
How big funds are accumulating CRISPR Therapeutics AG (1CG) stockPortfolio Risk Summary & Technical Entry and Exit Alerts - newser.com
Is CRISPR Therapeutics AG stock a buy for dividend growthJuly 2025 Rallies & Low Drawdown Investment Strategies - newser.com
CRISPR Therapeutics AG stock trendline breakdownJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Is CRISPR Therapeutics AG stock a top pick in earnings seasonJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com
CRISPR Therapeutics (CRSP) Gains as FDA Eases Approval Pathway - GuruFocus
Gene editing therapy companies rise on word of streamlined FDA approval process - Seeking Alpha
FDA to Expedite Gene-Editing Approval Process, Impacting CRSP - GuruFocus
FDA Clears Way for Faster Personalized Gene Editing Therapy - Bloomberg.com
Key metrics from CRISPR Therapeutics AG’s quarterly dataWeekly Trend Report & AI Forecasted Stock Moves - newser.com
Visual analytics tools that track CRISPR Therapeutics AG performanceQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Visualizing CRISPR Therapeutics AG stock with heatmapsEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Assessing CRISPR Therapeutics After First US Gene-Editing Therapy Spurs 47.5% Stock Surge - Sahm
Building trade automation scripts for CRISPR Therapeutics AG2025 Market WrapUp & Weekly High Return Stock Forecasts - newser.com
Can you recover from losses in CRISPR Therapeutics AG2025 Risk Factors & Technical Buy Zone Confirmations - newser.com
크리스퍼 테라퓨틱스 (CRSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
0.32%
자본화:
|
볼륨(24시간):